SCHEMBL6277017

SCHEMBL6277017

Clc1ccc(-c2nnc3cc(-c4ccncc4)ncn23)cc1Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CSNK1A1 P48729 2/20 0.47
▸ CLK4 Q9HAZ1 2/20 0.47
▸ ABL1 P00519 1/20 0.47
▸ PDGFRA P16234 1/20 0.47
▸ CDK7 P50613 1/20 0.47
▸ BTK Q06187 1/20 0.47
▸ MAP4K2 Q12851 1/20 0.47
▸ AURKB Q96GD4 1/20 0.47
▸ DYRK1B Q9Y463 1/20 0.47
▸ BCHE P06276 1/20 0.43
▸ NPY5R Q15761 1/20 0.42
▸ HPGD P15428 2/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ HSD11B1 P28845 1/20 0.39
▸ KMO O15229 5/20 0.39
▸ ALDH1A1 P00352 2/20 0.38
▸ LMNA P02545 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6279165 0.88 ABL1 (0.44) CSNK1A1CLK4ABL1PDGFRACDK7
SCHEMBL6277021 0.81 BCHE (0.39) CSNK1A1CLK4BCHENPY5RHPGD
SCHEMBL6280307 0.74 KDM4E (0.57) CSNK1A1CLK4ABL1PDGFRACDK7
SCHEMBL6279167 0.70 KDR (0.39) ABL1BCHEHPGDMEN1KMT2A
SCHEMBL6285208 0.67 KDM4E (0.46) CSNK1A1CLK4ABL1PDGFRACDK7
SCHEMBL16331371 0.64 GRK5 (0.50) BCHEKDM4EHSD17B10MAPK14FLT3
SCHEMBL32665254 0.63 ALDH1A1 (0.51) HPGDMEN1KMT2AHSD11B1ALDH1A1
SCHEMBL30429856 0.62 DCLK1 (0.61) CSNK1A1CLK4NPY5RHPGDKMO
SCHEMBL2163999 0.62 DCLK1 (0.61) CSNK1A1CLK4NPY5RHPGDKMO
SCHEMBL22148214 0.60 MAP4K4 (0.44) CSNK1A1CLK4ABL1PDGFRACDK7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6921762-B2 Substituted indolizine-like compounds and methods of use AMGEN INC. (US) 2005-07-26 — — US disclosed
Send feedback